Raras
Buscar doenças, sintomas, genes...
Micose fungoide e variantes
ORPHA:178566CID-10 · C84.0CID-11 · 2B01DOENÇA RARA

A micose fungóide (MF) e suas variantes representam as formas mais comuns de linfomas cutâneos de células T. O termo MF é restrito à forma clássica caracterizada pela progressão lenta de manchas, placas e tumores, e a variantes com curso indolente semelhante.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A micose fungóide (MF) e suas variantes representam as formas mais comuns de linfomas cutâneos de células T. O termo MF é restrito à forma clássica caracterizada pela progressão lenta de manchas, placas e tumores, e a variantes com curso indolente semelhante.

Publicações científicas
1.301 artigos
Último publicado: 2026 Apr 16
Medicamentos
10 registrados
DEXAMETHASONE SODIUM PHOSPHATE, PREDNISOLONE, MOGAMULIZUMAB

Tem tratamento?

10 medicamentos registrados
Ver detalhes, fases e interações →
DEXAMETHASONE SODIUM PHOSPHATEPREDNISOLONEMOGAMULIZUMABMETHOTREXATEDEXAMETHASONEPREDNISONEBEXAROTENEBRENTUXIMAB VEDOTINNALOXONEZANOLIMUMAB

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adult
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: C84.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧬
Pele e cabelo
16 sintomas
🩸
Sangue
5 sintomas
🫘
Rins
2 sintomas
🫃
Digestivo
2 sintomas
🦴
Ossos e articulações
1 sintomas
👁️
Olhos
1 sintomas

+ 10 sintomas em outras categorias

Características mais comuns

Linfoma
Linfoma de Hodgkin
Pele rígida
Nefrocalcinose
Hipercalcemia
Cutis laxa
38sintomas
Sem dados (38)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 38 características clínicas mais associadas, ordenadas por frequência.

LinfomaLymphoma
Linfoma de HodgkinHodgkin lymphoma
Pele rígidaStiff skin
NefrocalcinoseNephrocalcinosis
HipercalcemiaHypercalcemia

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.301PubMed
Últimos 10 anos200publicações
Pico202142 papers
Linha do tempo
2026Hoje · 2026🧪 2016Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

3 genes identificados com associação a esta condição. Padrão de herança: Not applicable.

CTLA4Cytotoxic T-lymphocyte protein 4Candidate gene tested inAltamente restrito
FUNÇÃO

Inhibitory receptor acting as a major negative regulator of T-cell responses (PubMed:11279501, PubMed:11279502, PubMed:16551244, PubMed:1714933, PubMed:18641304, PubMed:28484017). Acts as a decoy receptor: the affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28 (PubMed:11279501, PubMed:11279502, PubMed:16551244, PubMed:1714933, PubMed:28484017)

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (3)
Co-stimulation by CD28Co-inhibition by CTLA4RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
MECANISMO DE DOENÇA

Systemic lupus erythematosus

A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

EXPRESSÃO TECIDUAL(Tecido-específico)
Baço
5.8 TPM
Intestino delgado
4.9 TPM
Pulmão
4.3 TPM
Testículo
2.5 TPM
Sangue
1.8 TPM
OUTRAS DOENÇAS (6)
autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiencysystemic lupus erythematosusgranulomatosis with polyangiitismycosis fungoides
HGNC:2505UniProt:P16410
CD28T-cell-specific surface glycoprotein CD28Candidate gene tested inRestrito
FUNÇÃO

Receptor that plays a role in T-cell activation, proliferation, survival and the maintenance of immune homeostasis (PubMed:1650475, PubMed:7568038). Functions not only as an amplifier of TCR signals but delivers unique signals that control intracellular biochemical events that alter the gene expression program of T-cells (PubMed:24665965). Stimulation upon engagement of its cognate ligands CD80 or CD86 increases proliferation and expression of various cytokines in particular IL2 production in bo

LOCALIZAÇÃO

Cell membraneCell surface

VIAS BIOLÓGICAS (2)
Co-stimulation by CD28Nef mediated downregulation of CD28 cell surface expression
MECANISMO DE DOENÇA

Immunodeficiency 123 with HPV-related verrucosis

An autosomal recessive immunologic disorder characterized by susceptibility to human papilloma virus (HPV) infections and the development of HPV-related common verrucosis in the first decade of life. In some patients with HPV2 infection, warts may progress to severe generalized hyperkeratotic cutaneous papillomatosis with cutaneous horns ('tree-man' phenotype). In patients with HPV4 infection, warts remains stable and may even regress with age.

OUTRAS DOENÇAS (3)
immunodeficiency 123 with HPV-related verrucosismycosis fungoidesSezary syndrome
HGNC:1653UniProt:P10747
TNFRSF1BTumor necrosis factor receptor superfamily member 1BCandidate gene tested inModerado
FUNÇÃO

Receptor with high affinity for TNFSF2/TNF and approximately 5-fold lower affinity for homotrimeric TNFSF1/lymphotoxin-alpha. The TRAF1/TRAF2 complex recruits the apoptotic suppressors BIRC2 and BIRC3 to TNFRSF1B/TNFR2. This receptor mediates most of the metabolic effects of TNF. Isoform 2 blocks TNF-induced apoptosis, which suggests that it regulates TNF function by antagonizing its biological activity

LOCALIZAÇÃO

Cell membraneSecreted

VIAS BIOLÓGICAS (4)
Neutrophil degranulationTNFR2 non-canonical NF-kB pathwayTNFs bind their physiological receptorsInterleukin-4 and Interleukin-13 signaling
EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
474.3 TPM
Baço
180.8 TPM
Tecido adiposo
110.3 TPM
Linfócitos
105.9 TPM
Pulmão
100.4 TPM
OUTRAS DOENÇAS (2)
mycosis fungoidesSezary syndrome
HGNC:11917UniProt:P20333

Medicamentos e terapias

DEXAMETHASONE SODIUM PHOSPHATEPhase 4

Mecanismo: Glucocorticoid receptor agonist

PREDNISOLONEPhase 4

Mecanismo: Glucocorticoid receptor agonist

MOGAMULIZUMABPhase 4

Mecanismo: C-C chemokine receptor type 4 cross-linking agent

METHOTREXATEPhase 4

Mecanismo: Dihydrofolate reductase inhibitor

DEXAMETHASONEPhase 4

Mecanismo: Glucocorticoid receptor agonist

PREDNISONEPhase 4

Mecanismo: Glucocorticoid receptor agonist

BEXAROTENEPhase 3

Mecanismo: Retinoid X receptor agonist

BRENTUXIMAB VEDOTINPhase 3

Mecanismo: Tubulin inhibitor

NALOXONEPhase 3

Mecanismo: Opioid receptors; mu/kappa/delta antagonist

ZANOLIMUMABPhase 3

Mecanismo: T-cell surface antigen CD4 other

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

191 variantes patogênicas registradas no ClinVar.

🧬 TNFRSF1B: NM_001066.3(TNFRSF1B):c.1106-196G>A ()
🧬 TNFRSF1B: GRCh37/hg19 1p36.32-36.12(chr1:4436802-22782007)x2 ()
🧬 TNFRSF1B: GRCh37/hg19 1p36.31-36.21(chr1:6330828-12910774)x1 ()
🧬 TNFRSF1B: GRCh38/hg38 1p36.33-35.1(chr1:99125-34026935)x3 ()
🧬 TNFRSF1B: NC_000001.10:g.4481271_20530242del ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado6
3Fase 34
2Fase 21
1Fase 11
Medicamentos catalogadosEnsaios clínicos· 10 medicamentos · 2 ensaios
✓ Aprovados — podem ser usados hoje
DEXAMETHASONE SODIUM PHOSPHATEPREDNISOLONEMOGAMULIZUMABMETHOTREXATEDEXAMETHASONEPREDNISONE
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Micose fungoide e variantes

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

BK polyomavirus-associated progressive multifocal leukoencephalopathy following mogamulizumab therapy for erythrodermic mycosis fungoides.

Frontiers in cellular and infection microbiology2026

BK polyomavirus (BKPyV) is a ubiquitous human pathogen that typically causes nephropathy and hemorrhagic cystitis in immunocompromised patients. Although BKPyV shares close genetic and structural similarity with JC polyomavirus (JCPyV), which is responsible for progressive multifocal leukoencephalopathy (PML), its neurotropic potential remains poorly characterized. Rare reports have suggested possible central nervous system (CNS) involvement under conditions of severe immune suppression. Here, we describe the first documented case of BKPyV-associated PML in a patient with erythrodermic mycosis fungoides treated with Mogamulizumab, a CCR4-targeting monoclonal antibody that profoundly alters immune surveillance. We describe a patient with erythrodermic mycosis fungoides and long-standing immunological frailty, who developed neurological symptoms during Mogamulizumab therapy. Brain MRI showed multifocal white matter lesions compatible with PML. BKPyV DNA was detected in plasma, urine, and cerebrospinal fluid (CSF), while JCPyV DNA was absent. Serological testing showed high anti-BKPyV and anti-JCPyV IgG levels in plasma, indicating prior exposure to both viruses, while antibodies were undetectable in CSF, consistent with lack of intrathecal synthesis. This compartmental dissociation between plasma and CSF, together with the detection of BKPyV DNA and the absence of JCPyV DNA in CSF, supports BKPyV as the etiological neurotropic agent responsible for leukoencephalopathy. Sequencing of the VP1 and NCCR regions revealed compartment-specific nucleotide and amino acid variants, including non-conservative substitutions in the CSF isolate, suggesting intra-host viral heterogeneity. Compartment-specific sequence variability of viral protein 1 (VP1) and structural rearrangements of the non-coding control region (NCCR), particularly the loss of the Q and R block in CSF-derived isolates, underscore intra-host heterogeneity of BKV and may contribute to its adaptation and neurotropic potential. This is the first documented case of BKPyV-associated PML in a Mogamulizumab-treated patient. These findings highlight intra-host heterogeneity at the protein level, possibly reflecting compartment-specific viral evolution, and underscore the need for vigilant BKPyV and JCPyV monitoring during Mogamulizumab treatment.

#2

Evaluation of immunohistochemical and gene expression of Janus kinase1 and Janus kinase3 in the skin of different clinical types of mycosis fungoides patients - Part II: reverse transcriptase-polymerase chain reaction.

Anais brasileiros de dermatologia2026 Mar 19

Mycosis Fungoides (MF) is the commonest type of primary cutaneous T-Cell lymphomas representing about 50% of all lymphomas arising primarily in the skin. Janus kinases are non-receptor intracellular tyrosine kinases that play an important role in the pathogenesis of variant skin disorders and several hematological malignancies. The aim of this study was to investigate the gene expression of Janus Kinase-1 (JAK1) and Janus Kinase-3 (JAK3) in the skin of different types of MF patients using Real-time Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR). The current study included 53 patients with MF, and 53 control samples. RT-PCR for JAK1 and JAK3 was done in the skin specimens obtained from patients and controls. Both JAK1 and JAK3 fold changes showed stepwise upregulation in lesional MF skin than normal control skin, with statistically significant increase in MF patients than healthy controls (p < 0.001 and < 0.001 respectively). JAK1 was significantly upregulated in early-stage MF than JAK3 (p < 0.001). Limitations of this study include the small sample size of some mycosis fungoides variants, such as erythrodermic MF. Further studies are needed to clarify the functional role of Janus kinase signaling pathways in MF pathogenesis. Both JAK1 and JAK3 play a role in the pathogenesis of MF. JAK1 may have a pathogenic role, particularly in the early stage of cutaneous T-cell lymphoma. This potentiates the idea of using JAK1 and JAK3 inhibitors for MF treatment.

#3

Evaluation of immunohistochemical and gene expression of Janus kinase 1 and Janus kinase 3 in the skin of different clinical types of mycosis fungoides patients - Part 1.

Anais brasileiros de dermatologia2026 Mar 09

Mycosis fungoides is the commonest type of cutaneous T-Cell lymphoma. Janus kinases are intracellular tyrosine kinases that have recently been proven to have a crucial role in the pathogenesis and progression of several dermatological and malignant diseases. The aim of this study was to investigate the immunohistochemical expression of Janus Kinase-1 (JAK1) and Janus Kinase-3 (JAK3) in the skin of mycosis fungoides . The current study included 46 patients with early-stage MF, and 7 patients with late-stage MF, and 53 control samples. Immunohistochemical staining using JAK1 and JAK3 monoclonal antibodies was done in the skin specimens obtained from patients and controls. The evaluation of JAK1 and JAK3 gene expression using RT-PCR will be included in part 2 of the study. JAK1 immunohistochemical expression was nuclear, and JAK3 was cytoplasmic in MF patients. Immunoreactivity scores for JAK1 and JAK3 in MF patients were significantly increased compared to healthy controls (p < 0.001 and < 0.001, respectively). JAK1 and JAK3 immunoreactivity scores were significantly higher in the tumor than in the patch and plaque stages of MF (P7 = 0.001 and 0.004, respectively). This study is limited by the relatively small sample size of some clinical variants of mycosis fungoides, particularly advanced forms such as erythrodermic and tumor-stage MF. Further studies are needed to evaluate JAK1 and JAK3 expression following therapeutic interventions, including phototherapy and JAK inhibitors. JAK1 and JAK3 were significantly expressed in MF skin lesions in comparison to normal controls. JAK1 and JAK3 were more expressed in the tumor stage than patch and plaque stage MF, suggesting that JAK1 and JAK3 could play a crucial role in MF pathogenesis, progression, and prognosis.

#4

A historical review of mycosis fungoides: from Alibert to mogamulizumab.

Skin health and disease2026 Feb

In 1806, French physician Baron Jean-Louis Alibert saw a man with a desquamating rash and skin tumours. Alibert considered this to be a variant of yaws. In 1829 Alibert named the condition mycosis fungoides (MF), meaning 'mushroom-like fungal disease'. Over 100 years later, French dermatologist Albert Sézary published papers from 1938 to 1949 detailing a mysterious disease containing 'cellules monstrueuses', describing cutaneous 'monster cells'. In 1961, these clinical findings were collated together into 'Sézary syndrome'. In the 1870s English dermatologist William Tilbury Fox published a dermatology atlas detailing cases similar to what we know now as MF, with the name 'fibroma fungoides'. The atlas described MF as a type of fungus, before giving a description of yaws and painting a clinical picture that differed from that of a lymphoma. Over the twentieth century, our understandings of the origins of MF were changing and by 1975 the classification system and term we now recognize as cutaneous T-cell lymphoma (CTCL) was developed. Neoplastic cells have been thought to arise from chronic activation of T cells via antigen-presenting cells due to inappropriate cytokines and C-C chemokine receptors. In 2018, the World Health Organization and European Organisation for Research and Treatment of Cancer officially recognized four variants of MF. These are the classic Alibert-Bazin variant and its three variants: folliculotropic MF, pagetoid reticulosis and granulomatous slack skin. Developments in immunohistochemistry for the T-cell receptor gene in the 1990s improved the diagnosis of CTCL; however, diagnosis is still challenging. Advanced MF therapies have evolved from cytotoxic chemotherapy to novel monoclonal antibodies such as mogamulizumab, targeting proteins on T-cell lymphoma cells.

#5

Adult-Onset Hypopigmented Mycosis Fungoides: A Systematic Review of Clinicopathologic, Immunophenotypic, and Therapeutic Characteristics.

Cancers2026 Jan 15

Background/Objectives: Hypopigmented mycosis fungoides (hMF) is a rare variant of mycosis fungoides (MF) often seen in younger patients and individuals with darker skin phototypes. The lesions develop as hypopigmented patches or plaques, and they are usually asymptomatic and respond well to topical treatment or phototherapy. Methods: We provide a systematic review on hMF with onset at or beyond 30 years of age, based on SCOPUS, PubMed, and Embase databases. A total of 13 original articles, totaling 34 patients, were included in this review. Evidence was limited to case reports and small series; PROSPERO registration is CRD420251181894. Results: The majority of cases did not progress beyond stage IB and commonly used treatment methods, including topical corticosteroids and phototherapy. In three patients, a progression of the disease occurred, and in two of them it was fetal. Among patients receiving phototherapy, PUVA therapy achieved complete remission more often than UVB (13 out of 17 cases vs. 8 out of 16 cases). Although recurrences occurred with both treatments, they were less frequent, and relapses took longer to develop in the PUVA group. Conclusions: In this cohort, PUVA appeared to be associated with higher complete response rates and longer remission duration than UVB. However, this advantage of PUVA is derived from low-level evidence and should be confirmed in prospective comparative studies.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC2 artigos no totalmostrando 198

2026

Evaluation of immunohistochemical and gene expression of Janus kinase1 and Janus kinase3 in the skin of different clinical types of mycosis fungoides patients - Part II: reverse transcriptase-polymerase chain reaction.

Anais brasileiros de dermatologia
2026

Evaluation of immunohistochemical and gene expression of Janus kinase 1 and Janus kinase 3 in the skin of different clinical types of mycosis fungoides patients - Part 1.

Anais brasileiros de dermatologia
2026

BK polyomavirus-associated progressive multifocal leukoencephalopathy following mogamulizumab therapy for erythrodermic mycosis fungoides.

Frontiers in cellular and infection microbiology
2025

Efficacy and tolerability of mogamulizumab in mycosis fungoides and Sézary Syndrome: a monocentric retrospective study.

Frontiers in oncology
2026

A historical review of mycosis fungoides: from Alibert to mogamulizumab.

Skin health and disease
2026

Adult-Onset Hypopigmented Mycosis Fungoides: A Systematic Review of Clinicopathologic, Immunophenotypic, and Therapeutic Characteristics.

Cancers
2025

A Case of Folliculotropic Mycosis Fungoides Initially Misleading as a Poikilodermatous Rash: The Importance of Gene Rearrangement Testing in Early-Stage Disease (Folliculotropic T-Cell Lymphocytosis).

Cureus
2026

Relapsed/refractory mycosis fungoides and Sezary syndrome: biology, clinical manifestations and therapeutic options.

Leukemia &amp; lymphoma
2026

Immunoprofiling Reveals GATA3 as a Prognostic Marker in Transformed Mycosis Fungoides.

The Journal of dermatology
2025

Rapidly Progressing CD8-negative Hypopigmented Mycosis Fungoides in Adult Caucasian Male with Good Response to Mogamulizumab.

Acta dermato-venereologica
2025

Extensive Alopecia Mucinosa and Response to Brentuximab Vedotin: A Case Report.

Skin appendage disorders
2026

An Unusual Case of Primary Mucocutaneous Cytotoxic T-Cell Lymphoma With Epidermotropism and Phenotype Switch: Diagnostic and Molecular Insights.

Journal of cutaneous pathology
2025

Early-Onset Hypopigmented Mycosis Fungoides in a Young Female: Navigating Diagnostic Delays and Treatment Complexities-A Case Report.

Clinical case reports
2025

Retrospective Analysis of Second Primary Malignancies in Patients with Mycosis Fungoides and Sézary Syndrome in Croatia.

Dermatology practical &amp; conceptual
2026

CD30-Positive Lymphoproliferative Disorder With DUSP22-IRF4 Rearrangement and Gamma-Delta T-Cell Phenotype: A Novel Indolent Presentation.

Journal of cutaneous pathology
2026

Primary Cutaneous Diffuse Large B-Cell Lymphoma With Initial Atypical Clinical Presentation as Annular and Arcuate Plaques, Histologically Mimicking Interstitial Granulomatous Dermatitis.

The American Journal of dermatopathology
2025

Atrophic Pityriasis Versicolor: 3 Case Reports.

Case reports in dermatology
2025

A Case of Cutaneous T-cell Lymphoma: The Importance of a Dermatology Consultation.

Cureus
2025

Pediatric Papular Mycosis Fungoides Treated With Phototherapy: A Case Series.

Pediatric dermatology
2025

Vesiculobullous Eruption in Patient With Mycosis Fungoides.

The American Journal of dermatopathology
2025

Unexpected Diagnosis in a Cutaneous Tumoral Lesion: Primary Cutaneous Leg-Type B-Cell Lymphoma.

Cureus
2025

Successful Treatment of Poikilodermatous Mycosis Fungoides with 308-nm Excimer Laser.

Case reports in oncology
2026

Clinical and Prognostic Features of Erythrodermic Cutaneous T-Cell Lymphoma: A Retrospective Study of 35 Patients.

Turkish journal of haematology : official journal of Turkish Society of Haematology
2025

Durable Remission after Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for Refractory Mycosis Fungoides: A Case Report.

International journal of hematology-oncology and stem cell research
2025

Folliculotropic Mycosis Fungoides Masquerading as Nodulocystic Acne: A Diagnostic Challenge.

Cureus
2025

Family and Quality of Life Challenges in Mycosis Fungoides Patients: A Case-Control Study from Shiraz, Southern Iran.

Dermatology practical &amp; conceptual
2025

[Poikilodermatous mycosis fungoides].

Dermatologie (Heidelberg, Germany)
2025

An illustrative case of hypopigmented mycosis fungoides.

SAGE open medical case reports
2025

Anaplastic large cell lymphoma: unusual clinical and pathologic findings: A report of the 2023 SH-EA4HP Lymphoma Workshop.

American journal of clinical pathology
2025

Zosteriform Mycosis Fungoides: A Case Report and Literature Review.

The American Journal of dermatopathology
2025

Structural Insights into the ADCC Mechanism and Resistance of Mogamulizumab, a First-in-Class Anti-CCR4 Therapy for Cutaneous T Cell Lymphoma.

International journal of molecular sciences
2025

Folliculosebaceous Cystic Hamartoma With Unusual Mucinosis: A Report of a Rare Case.

Cureus
2025

Alopecia Mimicking Lichen Planopilaris in a Patient with Mycosis Fungoides.

Skin appendage disorders
2025

ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part one: diagnosis and staging.

The British journal of dermatology
2025

ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part two: treatment.

The British journal of dermatology
2025

Thyroid Dysfunction in Mycosis Fungoides: Sonographic and Laboratory Insights.

Dermatology practical &amp; conceptual
2025

Overexpression of FOXM1 drives mycosis fungoides progression by regulating the cell cycle.

Journal of dermatological science
2025

Photodynamic Therapy in Primary Cutaneous Skin Lymphoma-Systematic Review.

Journal of clinical medicine
2025

A Case Report on Juvenile Folliculotropic Mycosis Fungoides: A Misleading Disease.

Cureus
2025

A rare case of mycosis fungoides with porokeratosis-like lesions: a case report and review of previous literature.

AME case reports
2025

Dermoscopy of folliculotropic mycosis fungoides of the scalp: a pediatric case report with comparative trichoscopic analysis.

Dermatology reports
2025

Dermoscopic and trichoscopic features of follicular mycosis fungoides: a systematic review.

Italian journal of dermatology and venereology
2025

Successfully maintained complete remission of mycosis fungoides by umbilical cord blood transplantation: a case report and literature review.

Dermatology reports
2025

Central Nervous System Manifestations of Cutaneous Lymphomas.

Current neurology and neuroscience reports
2025

Melano-erythrodermic folliculotropic mycosis fungoides misdiagnosed as a case of recalcitrant atopic dermatitis: A case report.

SAGE open medical case reports
2025

HDAC10 and its implications in Sézary syndrome pathogenesis.

Frontiers in cell and developmental biology
2025

T-cell lymphoproliferative disorder with a STAT3 mutation causing a lymphocytic variant of hypereosinophilic-like syndrome without eosinophilia.

Journal of hematopathology
2025

Coexistence of T-Cell Lymphoblastic Lymphoma and Ichthyosis Vulgaris: A Case Report.

Case reports in oncological medicine
2025

Management of mycosis fungoides and Sézary syndrome with mogamulizumab in combination with psoralen plus UVA: two case reports.

Therapeutic advances in hematology
2025

Comparison of Pediatric- and Adult-Onset Mycosis Fungoides Patients in Terms of Clinical Features and Prognosis in a Large Series.

Journal of cutaneous medicine and surgery
2025

A Yale Dermatology perspective on cutaneous T cell lymphoma: Historic reflection to emerging therapies.

Clinics in dermatology
2024

CD4/CD8 double-negative mycosis fungoides: a review.

Dermatology reports
2024

Zosteriform mycosis fungoides: case report of progression to tumor stage and review of the literature.

Dermatology online journal
2024

A Case Report of Folliculotropic Mycosis Fungoides: Diagnostic Criteria and Treatment Strategy.

Cureus
2024

[Hypopigmented mycosis fungoide. Case report].

Revista medica del Instituto Mexicano del Seguro Social
2024

Folliculotropic mycosis fungoides with leukaemic involvement in middle childhood: a rare encounter.

BMJ case reports
2024

Radiation therapy for a case of poikilodermatous plaques in an otherwise healthy young man: A case report.

SAGE open medical case reports
2025

Seborrheic keratosis-like mycosis fungoides: A rare variant with clinical, dermatoscopic, and dermatopathological features.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2024

Pathogenic variants of mycosis fungoides identified using next-generation sequencing.

Journal of hematopathology
2024

When mycosis fungoides seems not to be within the spectrum of clinical and histopathological differential diagnoses.

Dermatology reports
2024

Clinical and Histologic Variants of CD8+ Cutaneous T-Cell Lymphomas.

Cancers
2024

Beyond the pale: Insights into hypopigmented mycosis fungoides - A case report.

Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia
2024

[Bullous mycosis fungoides-clinical indicator for an aggressive course of disease].

Dermatologie (Heidelberg, Germany)
2024

Atypical presentation of γ/δ mycosis fungoides with an unusual phenotype and SOCS1 mutation.

Open life sciences
2024

A case report of refractory advanced-stage mycosis fungoides: successful treatment and improved patient quality of life with mogamulizumab.

Therapeutic advances in hematology
2024

Cutaneous Lymphoma in a Tertiary Skin Hospital and Referral Centre in Nepal.

Journal of Nepal Health Research Council
2024

Mycosis Fungoides Palmaris et Plantaris Mimicking "Dyshidrotic Eczema": A Case Report.

Journal of drugs in dermatology : JDD
2024

Report on a Rare Case of Limited CD4/CD8 Double-Positive Paget Reticulosis with Literature Review.

Clinical, cosmetic and investigational dermatology
2024

Null T-cell phenotype mycosis fungoides with aberrant CD20 and CD56 expression: A diagnostic dilemma.

Journal of cutaneous pathology
2024

Folliculotropic mycosis fungoides associated with follicular mucinosis: A case report and mini review.

Clinical case reports
2024

Vitamin D in Cutaneous T-Cell Lymphoma.

Cells
2024

Lymphomatoid Papulosis With T-cell Receptor-Gamma Delta Expression: A Clinicopathologic Case-series of 26 Patients of an Underrecognized Immunophenotypic Variant of Lymphomatoid Papulosis.

The American journal of surgical pathology
2024

Waxy papules, infiltrated alopecic plaques, and shin ichthyosis.

International journal of dermatology
2023

Pigmented purpura dermatosis-like mycosis fungoides: four case reports and a review of published cases.

European journal of dermatology : EJD
2024

Immunobiology and treatment of cutaneous T-cell lymphoma.

Expert review of clinical immunology
2024

Risk of progression of early-stage mycosis fungoides, 10-year experience.

Anais brasileiros de dermatologia
2024

Clinical, histopathological and immunohistochemical evaluation of ultraviolet A1 treatment in early-stage mycosis fungoides.

Photodermatology, photoimmunology &amp; photomedicine
2023

Cutaneous T-Cell Lymphoma (CTCL) Arising Post Kidney Transplant: A Review of Clinical Variants in the Literature.

Hematology reports
2024

Successful anti-tumor effects with two novel bifunctional chemotherapeutic compounds that combine a LAT1 substrate with cytotoxic moieties in aggressive T-cell lymphomas.

Leukemia research reports
2024

Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome.

The Journal of investigative dermatology
2023

Folliculotropic Mycosis Fungoides In A Child: A Rare Case.

JPMA. The Journal of the Pakistan Medical Association
2023

Dermoscopy in the Diagnosis of Mycosis Fungoides: Can it Help?

Dermatology practical &amp; conceptual
2023

Folliculotropic Mycosis Fungoides Is Associated with Decreased PD1 Staining Compared with Classic Mycosis Fungoides.

Dermatopathology (Basel, Switzerland)
2023

Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates.

Human pathology
2023

Case Report: Mycosis fungoides as an exclusive manifestation of common variable immunodeficiency in a family with a NFKB2 gene mutation.

Frontiers in oncology
2023

mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy.

Cancers
2023

[Eczema and its treatment in older adults].

Dermatologie (Heidelberg, Germany)
2023

Clinical Outcomes of COVID-19 in Mycosis Fungoides and Sezary Syndrome.

Acta haematologica
2023

Paediatric Mycosis Fungoides: Clinical Variants, Treatment Modalities and Response to Therapy.

Acta dermato-venereologica
2023

Eyelid involvement of primary cutaneous lymphomas: A clinical perspective.

The Australasian journal of dermatology
2023

Follicular mycosis fungoides: Clinicohistopathologic features and outcomes in a series of 12 Chinese cases.

Indian journal of dermatology, venereology and leprology
2023

Emergence of Malignant T-Cell Intraclonal CDR3 Variants in Mycosis Fungoides.

JAMA dermatology
2023

Unusual case of adult-onset cutaneous lupus erythematosus mimicking early mycosis fungoides.

Oxford medical case reports
2023

Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma.

Cancers
2023

Two Different Variants of Mycosis Fungoides (Hypopigmented Mycosis Fungoides and Mycosis Fungoides Palmaris et Plantaris) Occurring Simultaneously in a Single Patient.

Indian journal of dermatology
2023

Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management.

Frontiers in oncology
2023

Pityriasis Lichenoides-Like Mycosis Fungoides: A Case Report.

Cureus
2023

Clinicopathologic characteristics and outcomes of patients with mycosis fungoides: A single tertiary center retrospective analysis in Saudi Arabia.

Saudi medical journal
2023

Are we there yet? cellular therapies for cutaneous T cell lymphoma.

Current research in translational medicine
2023

Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review.

Journal of cutaneous pathology
2023

Mycosis fungoides with Psoriasiform plaques: A case report and review of the literature.

Clinical case reports
2023

Hypopigmented Mycosis Fungoides in an 11-Year-Old Palestinian Boy.

Case reports in dermatological medicine
2023

Multidisciplinary Approach to the Diagnosis and Therapy of Mycosis Fungoides.

Healthcare (Basel, Switzerland)
2023

Distribution and clinical features of lymphomas involving skin in Taiwan.

The Kaohsiung journal of medical sciences
2023

Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources.

Dermatology research and practice
2022

Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma.

Genes
2022

Syringotropic Mycosis Fungoides: A Variant of Folliculotropic or a Distinct Subtype of Adnexotropic Mycosis Fungoides?

Journal of drugs in dermatology : JDD
2022

Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations.

Cancer management and research
2022

Diagnostic Outcomes and Treatment Modalities in Patients with Mycosis Fungoides in West Sweden-A Retrospective Register-Based Study.

Cancers
2022

Unraveling the Structural Variations of Early-Stage Mycosis Fungoides-CD3 Based Purification and Third Generation Sequencing as Novel Tools for the Genomic Landscape in CTCL.

Cancers
2022

Folliculotropic Mycosis Fungoides: Current Guidance and Experience from Clinical Practice.

Clinical, cosmetic and investigational dermatology
2022

Interstitial Mycosis Fungoides: An Unusual Mimic of Interstitial Granuloma Annulare Not to Miss.

Case reports in dermatological medicine
2022

[Quality of life of patients with mycosis fungoides and Sézary syndrome].

Dermatologie (Heidelberg, Germany)
2022

Pityriasis Lichenoides Et Varioliformis Acuta and Lymphomatoid Papulosis Type F: A Case Report of Two Entities in One Patient.

Clinical, cosmetic and investigational dermatology
2022

Folliculotropic Mycosis Fungoides in a Latin American Hospital: Survival Analysis.

Actas dermo-sifiliograficas
2022

Extragenital lichen sclerosus: A comprehensive review.

The Australasian journal of dermatology
2022

Localized lymphomatoid papulosis: Unilesional lymphomatoid papulosis, regional lymphomatoid papulosis, and persistent agmination of lymphomatoid papulosis.

Clinics in dermatology
2022

Deepening the observation of mycosis fungoides through dermoscopy: definition of the dermoscopic profiles of its progression stages and variants.

Journal of the European Academy of Dermatology and Venereology : JEADV
2022

CD4/CD8 double-negative mycosis fungoides with large cell transformation and involvement of the lungs and leptomeninges.

Dermatology online journal
2022

Hyper-IgE and Carcinoma in CADINS Disease.

Frontiers in immunology
2022

Paediatric mycosis fungoides - characteristics, management and outcomes with particular focus on the folliculotropic variant.

Journal of the European Academy of Dermatology and Venereology : JEADV
2023

Woringer-Kolopp disease (localized pagetoid reticulosis): a systematic review.

International journal of dermatology
2022

Oncolytic effect of SARS-CoV-2 in a patient with mycosis fungoides: A case report.

Clinical case reports
2022

[Mycosis fungoides and Sézary syndrome : a systematic review].

Revue medicale suisse
2022

Dermoscopic spectrum of mycosis fungoides: a retrospective observational study by the International Dermoscopy Society.

Journal of the European Academy of Dermatology and Venereology : JEADV
2022

Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma.

Cells
2022

Hyperpigmented mycosis fungoides: a retrospective and comparative analysis with other subtypes of mycosis fungoides.

Leukemia &amp; lymphoma
2022

Malignant T Cell Activation by a Bacillus Species Isolated from Cutaneous T-Cell Lymphoma Lesions.

JID innovations : skin science from molecules to population health
2022

Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders.

JID innovations : skin science from molecules to population health
2021

The Role of microRNA in Pathogenesis, Diagnosis, Different Variants, Treatment and Prognosis of Mycosis Fungoides.

Frontiers in oncology
2022

Interleukin (IL)-33 immunobiology in asthma and airway inflammatory diseases.

The Journal of asthma : official journal of the Association for the Care of Asthma
2022

CD8+ mycosis fungoides with ichthyosiform clinical presentation and angiocentric feature.

Journal of cutaneous pathology
2022

Use of Ultrasound to Observe Mycosis Fungoides: A Case Report and Review of Literature.

Current medical imaging
2021

Understanding the enigmatic association between mycosis fungoides and psoriasis: Report of two cases and review of the literature.

Metabolism open
2021

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling.

Journal of visualized experiments : JoVE
2021

New insights into granulomatous mycosis fungoides (GMF): a single-center experience.

European journal of cancer (Oxford, England : 1990)
2021

Primary cutaneous lymphomas in children: A prospective study from the Spanish Academy of Dermatology and Venereology (AEDV) Primary Cutaneous Lymphoma Registry.

Pediatric dermatology
2021

Management of a Unique Presentation of a Common Dermatologic Condition.

Spartan medical research journal
2022

Clinical characteristics and prognostic factors of 70 patients with Sézary syndrome: a single-institutional experience at Moffitt cancer center.

Leukemia &amp; lymphoma
2022

Interleukin 36 expression in psoriasis variants and other dermatologic diseases with psoriasis-like histopathologic features.

Journal of cutaneous pathology
2021

Evaluation of Melanocyte Loss in Mycosis Fungoides Using SOX10 Immunohistochemistry.

Dermatopathology (Basel, Switzerland)
2021

Primary Cutaneous Lymphomas in Thailand: A 10-Year Retrospective Study.

BioMed research international
2021

Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures.

Blood
2021

A Previously Unrecognized Granulomatous Variant of Gamma-Delta T-Cell Lymphoma.

Dermatopathology (Basel, Switzerland)
2022

Clinical characteristics and long-term outcome of 223 patients with mycosis fungoides at a single tertiary center in Korea: A 29-year review.

Journal of the American Academy of Dermatology
2021

Hypopigmented mycosis fungoides mimicking leprosy successfully treated with oral and topical corticosteroids: a new great imitator?

Acta dermatovenerologica Alpina, Pannonica, et Adriatica
2021

Clinical variants of mycosis fungoides in a cohort.

Gaceta medica de Mexico
2021

Dermoscopic Features of Mycosis Fungoides and Its Variants in Patients with Skin of Color: A Retrospective Analysis.

Dermatology practical &amp; conceptual
2021

[Papular mycosis fungoides in elderly: Report of two cases].

Revista espanola de geriatria y gerontologia
2021

Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity.

Blood
2021

Different aspects and variants of mycosis fungoides in a single patient.

Indian journal of dermatology, venereology and leprology
2021

Adnexotropic Variants of the Interface Dermatitides: A Review.

Dermatopathology (Basel, Switzerland)
2021

Diagnosis and Management of Cutaneous Lymphomas Including Cutaneous T-cell Lymphoma.

The Medical clinics of North America
2021

Serum and cutaneous transcriptional expression levels of IL31 are minimal in cutaneous T cell lymphoma variants.

Biochemistry and biophysics reports
2021

Clinical and trichoscopic features in 18 cases of Folliculotropic Mycosis Fungoides with scalp involvement.

Scientific reports
2021

Clinical characteristics and long-term outcomes of 97 Korean patients with mycosis fungoides.

International journal of dermatology
2021

Primary cutaneous T-cell lymphomas in childhood and adolescence.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2021

Cell signaling in cutaneous T-cell lymphoma microenvironment: promising targets for molecular-specific treatment.

International journal of dermatology
2021

Erythrodermic CD4/CD8 Double-Negative Mycosis Fungoides: A Case Report.

Case reports in oncology
2021

Mycosis Fungoides in Children and Adolescents: A Systematic Review.

JAMA dermatology
2021

Mycosis Fungoides with Dermal Mucin Deposition: An Unusual Variant of the Most Challenging Primary Cutaneous Lymphoma.

Case reports in dermatology
2021

Pembrolizumab in mycosis fungoides with PD-L1 structural variants.

Blood advances
2021

Granulomatous slack skin variant of mycosis fungoides: Clinical and dermoscopic follow-up of a very rare entity.

Dermatologic therapy
2021

Acneiform Presentations of Folliculotropic Mycosis Fungoides.

The American Journal of dermatopathology
2021

JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL).

Cancers
2021

Interstitial granuloma after interferon-gamma and narrowband UVB therapy in a patient with mycosis fungoides: Immunological and histopathological considerations.

Journal of cutaneous pathology
2021

Secondary hypereosinophilic syndrome: an unusual manifestation in a patient with syringotropic mycosis fungoides and human immunodeficiency virus infection.

The Australasian journal of dermatology
2021

Cutaneous T-cell lymphoma mimicking palmoplantar pustular psoriasis: A rare variant.

The Australasian journal of dermatology
2021

Lichen aureus with pseudolymphomatous infiltrate.

Journal of cutaneous pathology
2021

Adult T-cell leukemia/lymphoma clinically confused with viral/drug skin eruptions and pathologically misinterpreted as mycosis fungoides/Sézary syndrome.

Journal of cutaneous pathology
2020

Woringer-Kolopp Disease of the Foot: A Case Report.

Journal of the American Podiatric Medical Association
2021

Hypopigmented Mycosis Fungoides: A Clinical and Histopathology Analysis in 9 Children.

The American Journal of dermatopathology
2020

A Rare Case of Poikilodermatous Mycosis Fungoides.

Indian journal of dermatology
2021

Hypopigmented Mycosis Fungoides Mimicking Vitiligo.

The American Journal of dermatopathology
2021

Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry.

The British journal of dermatology
2021

Comparison between the histopathological and immunophenotypical features of hypopigmented and nonhypopigmented mycosis fungoides: A retrospective study.

Journal of cutaneous pathology
2020

Mycosis Fungoides Palmaris et Plantaris on the Plantar Aspect of the Foot: A Case Report.

The American journal of case reports
2020

Collisional variant of CD8+ mycosis fungoides and indolent CD8+ lymphoid proliferation.

JAAD case reports
2020

Single-Cell Heterogeneity of Cutaneous T-Cell Lymphomas Revealed Using RNA-Seq Technologies.

Cancers
2020

Hypopigmented Mycosis Fungoides: Loss of Pigmentation Reflects Antitumor Immune Response in Young Patients.

Cancers
2021

Aggressive CD4/CD8 Double-Negative Primary Cutaneous T-Cell Lymphoma With Dural Invasion: A Rare Presentation of Mycosis Fungoides?

The American Journal of dermatopathology
2020

Rare case of CD8+ CD56+ cytotoxic variant of mycosis fungoides clinically presenting with a combination of hypopigmentation and poikiloderma.

International journal of dermatology
2020

Ki67 and CD31 Differential Expression in Cutaneous T-Cell Lymphoma and Its Mimickers: Association with Clinicopathological Criteria and Disease Advancement.

Clinical, cosmetic and investigational dermatology
2020

Stage-dependent Increase in Expression of miR-155 and Ki-67 and Number of Tumour-associated Inflammatory Cells in Folliculotropic Mycosis Fungoides.

Acta dermato-venereologica
2020

Is it mycosis fungoides? A comprehensive guide to reaching the diagnosis and avoiding common pitfalls.

Annals of diagnostic pathology
2020

Lichen planus follicularis tumidus: Immunotyping of the inflammatory infiltrate with focus on plasmacytoid dendritic cells.

Journal of cutaneous pathology
2021

A Case Report of Pityriasis Lichenoides-Like Mycosis Fungoides in Children: A Challenging Diagnosis.

Korean journal of family medicine
2020

New Insights Into the Complex Mutational Landscape of Sézary Syndrome.

Frontiers in oncology
2020

Cutaneous T-cell lymphoma: aetiopathogenesis and current diagnostic and therapeutic developments.

European journal of dermatology : EJD
2020

Patch-type granuloma annulare: An institution-based study of 23 cases.

Journal of cutaneous pathology
2020

[Clinical heterogeneity of poikilodermatous mycosis fungoides: A retrospective study of 12 cases].

Annales de dermatologie et de venereologie
2020

Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma.

The Yale journal of biology and medicine
2020

Pilot Study of a Novel Therapeutic Approach for Refractory Advanced Stage Folliculotropic Mycosis Fungoides.

Acta dermato-venereologica
2020

Mycosis Fungoides, Lymphomatoid Papulosis and Hodgkin's Lymphoma in the Same Patient: Apropos of a Possible Monoclonal Origin.

Indian journal of dermatology
2020

Mycosis Fungoides and Variants of Mycosis Fungoides: A Retrospective Study of 93 Patients in a Chinese Population at a Single Center.

Annals of dermatology
2020

[LINEAR MYCOSIS FUNGOIDES IN A BLASCHKOID DISTRIBUTION].

Harefuah
2021

Thymocyte selection-associated high-mobility group box as a potential diagnostic marker differentiating hypopigmented mycosis fungoides from early vitiligo: A pilot study.

Indian journal of dermatology, venereology and leprology
2020

Pagetoid reticulosis in a 13-year old female. A unique immunohistochemical profile.

Journal of cutaneous pathology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Micose fungoide e variantes.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Micose fungoide e variantes

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. BK polyomavirus-associated progressive multifocal leukoencephalopathy following mogamulizumab therapy for erythrodermic mycosis fungoides.
    Frontiers in cellular and infection microbiology· 2026· PMID 41716458mais citado
  2. Evaluation of immunohistochemical and gene expression of Janus kinase1 and Janus kinase3 in the skin of different clinical types of mycosis fungoides patients - Part II: reverse transcriptase-polymerase chain reaction.
    Anais brasileiros de dermatologia· 2026· PMID 41861759mais citado
  3. Evaluation of immunohistochemical and gene expression of Janus kinase 1 and Janus kinase 3 in the skin of different clinical types of mycosis fungoides patients - Part 1.
    Anais brasileiros de dermatologia· 2026· PMID 41806757mais citado
  4. A historical review of mycosis fungoides: from Alibert to mogamulizumab.
    Skin health and disease· 2026· PMID 41646541mais citado
  5. Adult-Onset Hypopigmented Mycosis Fungoides: A Systematic Review of Clinicopathologic, Immunophenotypic, and Therapeutic Characteristics.
    Cancers· 2026· PMID 41595185mais citado
  6. Real-World Outcomes of Mycosis Fungoides and Site-Specific Nodal Involvement: A Registry-Based Study of 25 467 Patients.
    Am J Hematol· 2026· PMID 41988991recente
  7. A First-of-Its-Kind Case of Annular Lichenoid Dermatitis of Youth (ALDY) From Kuwait.
    Cureus· 2026· PMID 41970073recente
  8. Self-supervised AI system for differentiating mycosis fungoides and benign inflammatory dermatoses.
    Br J Dermatol· 2026· PMID 41967134recente
  9. Persistence of sex differences and stable trends in mortality in patients with mycosis fungoides and Sézary syndrome in Spain (1983-2022).
    Med Clin (Barc)· 2026· PMID 41722141recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:178566(Orphanet)
  2. MONDO:0015821(MONDO)
  3. GARD:20166(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q55785742(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Micose fungoide e variantes
Compêndio · Raras BR

Micose fungoide e variantes

ORPHA:178566 · MONDO:0015821
Prevalência
Unknown
Herança
Not applicable
CID-10
C84.0 · Micose fungóide
CID-11
Medicamentos
10 registrados
Início
Adult
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1513782
Repurposing
6 candidatos
flutrimazolesterol demethylase inhibitor
methylprednisoloneglucocorticoid receptor agonist
methylprednisolone-sodium-succinatemicrotubule inhibitor|tubulin polymerization inhibitor
+3 outros
EuropePMC
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades